Antithrombotic effects of LB30870, a potent, orally active, selective and direct thrombin inhibitor, and pharmacokinetics of its prodrug

The determination of enzyme inhibitor constants

Martin Dixon · Biochemical Journal · 1953 · 4.1K citations · Full text

Life Sciences, Biochemistry, Biochemical Pharmacology +15

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

Joachim Stangier, Karin Rathgen, Hildegard Stähle et al. · British Journal of Clinical Pharmacology · 2007 · 884 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans

Stefan Blech, Thomas Ebner, Eva Ludwig-Schwellinger et al. · Drug Metabolism and Disposition · 2007 · 682 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement

Geneviève Freyburger, G. Maçouillard, Sylvie Labrouche et al. · Thrombosis Research · 2011 · 156 citations

Medicine, Orthopedic Surgery, Surgery +17

Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans

Ulf G. Eriksson, Ulf Bredberg, Kurt‐Jürgen Hoffmann et al. · Drug Metabolism and Disposition · 2003 · 155 citations

Pharmacy, Pharmacokinetics, Pharmacology +16